Establishing the Nordic node of the COVID-19 host genetics initiative

Key facts

Disease
COVID-19
start year
-99
Known Financial Commitments (USD)
$0
Funder
Nordic Trial Alliance (NTA)
Principal Investigator
Andrea Ganna
Research Location
Finland
Lead Research Institution
FIMM, Finland
Research Priority Alignment
N/A

Research Category
Epidemiological studies
Research Subcategory
Disease susceptibility
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable

Abstract

The COVID-19 host genetics initiative is a bottom-up collaborative effort that has three main goals: Provide an environment to foster the sharing of resources to facilitate COVID-19 host genetics research (e.g. protocols, questionnaires). Organize analytical activities across studies to identify genetic determinants of COVID-19 susceptibility and severity. Provide a platform to share the results from such activities, as well as the individual-level data where possible, to benefit the broader scientific community.

Publicationslinked via Europe PMC

Last Updated:4 hours ago

View all publications at Europe PMC

Developing injury and illness epidemiology and surveillance in cycling (PhD Academy Award).

Effects of Hand-Rearing and Group Size on Chimpanzee (Pan troglodytes) Social Competence in Captivity.

Revisiting Spirituality in Physical Therapy Practice: Perceptions of US Practitioners.

Aflibercept for Wet Age-Related Macular Degeneration: A Prospective, Randomized Trial Comparing Treat-And-Extend and Fixed Bimonthly Dosing.

The Concentration and Duration of Lipopolysaccharide Stimulation Produce Different Cytokine Responses in an Ex Vivo Whole Blood Model in Horses.

History of Shrimp Farming and the Main Viral and Bacterial Diseases in Mexico.

Identification of Risk Factors in Patients with Recurrent Cystitis May Improve Individualized Management.

ISApl4, a New IS1595 Family Insertion Sequence Forming a Novel Pseudo-Compound Transposon That Confers Antimicrobial Multidrug Resistance in Actinobacillus pleuropneumoniae.